MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Conditions: Diabetic Macular Edema; Macular Edema; Type 2 Diabetes With Diabetic Macular Edema; Type 1 Diabetes With Diabetic Macular Edema; Diabetic Retinopathy Intervention: Drug: MS-553 Sponsors: Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.; Fountain Medical Development Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials